March 12th, 2015|
It seems as though the male patients who developed a condition known as gynecomastia as a result of taking the drug Risperdal® are finally receiving the compensation they deserve. A decision has been reached in favor of the plaintiffs in two separate Risperdal® drug injury lawsuits.
In late February, a Philadelphia jury found Johnson & Johnson—the maker of the defective drug—had failed to properly warn patients of the dangers the drug posed despite having information regarding the risks. The jury awarded the victim and his family a total of $2.5 million in damages.
This wasn’t the only recent court decision that was in favor of Risperdal® victims though. According to Reuters, the South Carolina Supreme Court ordered Johnson & Johnson to pay $136 million for their improper marketing of the medication. The courts initially ordered the drug manufacturer to pay $327 million, but the penalties were reduced due to statutes of limitations affecting the claims.
The cases show that there is still time for victims who suffered devastating Risperdal® side effects to be compensated for their injuries and losses; however, the drug injury lawyers with Fleschner, Stark, Tanoos & Newlin would like to remind you that time is of the essence when filling such a claim. So, it may be wise to discuss your condition with a qualified legal representative sooner, rather than later. Call us today at (800) 477-7315 to get a free consultation of your claim.